Minerva Neurosciences, Inc. (NERV) stock
Close on Nov 17, 2026Market cap $103.14MP/E –Yield –
Earnings
Minerva Neurosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Minerva Neurosciences's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 10, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 6, 2026before the open | – | – | -$0.19 | – | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 7, 2026before the open | – | – | -$0.14 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026before the open | – | – | -$2.86 | -$0.17 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 11, 2026before the open | – | – | -$25.51 | -$0.64 | Release |
| Q4 FY2014ended Dec 31, 2014 | Mar 26, 2015during market hours | – | – | – | – | Filing |
| Q3 FY2014ended Sep 30, 2014 | Nov 6, 2014during market hours | – | – | – | – | Filing |
| Q2 FY2014ended Jun 30, 2014 | Aug 7, 2014during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Minerva Neurosciences has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Minerva Neurosciences puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Minerva Neurosciences filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Results
- Results
- Update
- Results
- Update
- Update
- News
- News
- News
- News
- News
- News
See a number that looks wrong?